Co-infection mathematical model for HIV/AIDS and tuberculosis with optimal control in Ethiopia.

PLoS One

Department of Mathematical Sciences, College of Science, Engineering and Technology, University of South Africa, South Africa.

Published: December 2024

The co-epidemics of HIV/AIDS and Tuberculosis (TB) outbreak is one of a serious disease in Ethiopia that demands integrative approaches to combat its transmission. In contrast, epidemiological co-infection models often considered a single latent case and recovered individuals with TB. To bridge this gap, we presented a new optimal HIV-TB co-infection model that considers both high risk and low risk latent TB cases with taking into account preventive efforts of both HIV and TB diseases, case finding for TB and HIV/AIDS treatment. This study aimed to develop optimal HIV/AIDS-TB co-infection mathematical model to explore the best cost-effective measure to mitigate the disease burden. The model is analysed analytically by firstly segregating TB and HIV only sub models followed by the full TB-HIV co-infection model. The Disease Free Equilibrium (DFE) and Endemic Equilibrium (EE) points are found and the basic reproduction number R0 is obtained using the next generation matrix method (NGM). Based on the threshold value R0, the stabilities of equilibria for each sub-model are analysed. The DFE point is locally asymptotically stable when R0 < 1 and unstable when R0 > 1. The EE point is also asymptotically stable when R0 > 1 and does not exist otherwise. At R0 = 1, the existence of backward bifurcation phenomena is discussed. To curtail the cost and disease fatality, an optimal control model is formulated via time based controlling efforts. The optimal mathematical model is analysed both analytically and numerically. The numerical results are presented for two or more control measures at a time. In addition, the Incremental Cost-Effectiveness Ratio(ICER) has identified the best strategy which is crucial in limited resource. Hence, the model outcomes illustrated that applying HIV/AIDS prevention efforts and TB case finding concurrently is the most cost-effective strategy to offer substantial relief from the burden of the pandemic in the community. All results found in this study have significant public health lessons. We anticipated that the results will notify evidence based approaches to control the disease. Thus, this study will aids in the fight against HIV/AIDS, TB, and their co-infection policy-makers and other concerned organizations.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11630616PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0312539PLOS

Publication Analysis

Top Keywords

mathematical model
12
co-infection mathematical
8
model
8
hiv/aids tuberculosis
8
optimal control
8
co-infection model
8
case finding
8
model analysed
8
analysed analytically
8
asymptotically stable
8

Similar Publications

People living with HIV (PLWH) experience HIV-associated neurocognitive disorders (HAND), even though combination antiretroviral therapy (cART) suppresses HIV replication. HIV-1 transactivator of transcription (HIV-1 Tat) contributes to the development of HAND through neuroinflammatory and neurotoxic mechanisms. C-C chemokine 5 receptor (CCR5) is important in immune cell targeting and is a co-receptor for HIV viral entry into CD4+ cells.

View Article and Find Full Text PDF

Structural determinants of oxygen resistance and Zn-mediated stability of the [FeFe]-hydrogenase from .

Proc Natl Acad Sci U S A

January 2025

Laboratory for Protein Crystallography, Institute for Protein Research, Osaka University, Suita, Osaka 565-0871, Japan.

[FeFe]-hydrogenases catalyze the reversible two-electron reduction of two protons to molecular hydrogen. Although these enzymes are among the most efficient H-converting biocatalysts in nature, their catalytic cofactor (termed H-cluster) is irreversibly destroyed upon contact with dioxygen. The [FeFe]-hydrogenase CbA5H from has a unique mechanism to protect the H-cluster from oxygen-induced degradation.

View Article and Find Full Text PDF

A divergent two-domain structure of the anti-Müllerian hormone prodomain.

Proc Natl Acad Sci U S A

January 2025

Department of Molecular & Cellular Biosciences, University of Cincinnati, Cincinnati, OH 45267.

TGFβ family ligands are synthesized as precursors consisting of an N-terminal prodomain and C-terminal growth factor (GF) signaling domain. After proteolytic processing, the prodomain typically remains noncovalently associated with the GF, sometimes forming a high-affinity latent procomplex that requires activation. For the TGFβ family ligand anti-Müllerian hormone (AMH), the prodomain maintains a high-affinity interaction with its GF that does not render it latent.

View Article and Find Full Text PDF

Theory and simulations are used to demonstrate implementation of a variational Bayes algorithm called "active inference" in interacting arrays of nanomagnetic elements. The algorithm requires stochastic elements, and a simplified model based on a magnetic artificial spin ice geometry is used to illustrate how nanomagnets can generate the required random dynamics. Examples of tracking and PID control are demonstrated and shown to be consistent with the original stochastic differential equation formulation of active inference.

View Article and Find Full Text PDF

Astrocytes critically shape whole-brain structure and function by forming extensive gap junctional networks that intimately and actively interact with neurons. Despite their importance, existing computational models of whole-brain activity ignore the roles of astrocytes while primarily focusing on neurons. Addressing this oversight, we introduce a biophysical neural mass network model, designed to capture the dynamic interplay between astrocytes and neurons via glutamatergic and GABAergic transmission pathways.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!